ALKEM LABORATORIES
Back to Income Statement
|
ALKEM LABORATORIES Last 5 Year Consolidated Net Profit History
[Consolidated]
Mar2024 | Mar2023 | Mar2022 | Mar2021 | Mar2020 | |
---|---|---|---|---|---|
Consolidated Net Profit | ₹1,796 Cr | ₹984 Cr | ₹1,646 Cr | ₹1,585 Cr | ₹1,127 Cr |
What is the latest Consolidated Net Profit of ALKEM LABORATORIES ?
Year | Consolidated Net Profit |
---|---|
Mar2024 | ₹1,796 Cr |
Mar2023 | ₹984 Cr |
Mar2022 | ₹1,646 Cr |
Mar2021 | ₹1,585 Cr |
Mar2020 | ₹1,127 Cr |
How is Consolidated Net Profit of ALKEM LABORATORIES Trending?
Years | Consolidated Net Profit | % Change | |
---|---|---|---|
Mar2024 | ₹1,796 Cr | 82.47 | |
Mar2023 | ₹984 Cr | -40.19 | |
Mar2022 | ₹1,646 Cr | 3.82 | |
Mar2021 | ₹1,585 Cr | 40.63 | |
Mar2020 | ₹1,127 Cr | - |
Compare Consolidated Net Profit of peers of ALKEM LABORATORIES
Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
ALKEM LABORATORIES | ₹55,433.4 Cr | 0.6% | -8.4% | -8.5% | Stock Analytics | |
SUN PHARMACEUTICAL INDUSTRIES | ₹382,430.0 Cr | -3% | -8.7% | 4.1% | Stock Analytics | |
DIVIS LABORATORIES | ₹145,410.0 Cr | -4.7% | -4.5% | 58.5% | Stock Analytics | |
CIPLA | ₹113,950.0 Cr | -4.3% | -3.2% | -3.2% | Stock Analytics | |
TORRENT PHARMACEUTICALS | ₹99,682.3 Cr | -3% | -12.3% | 13.8% | Stock Analytics | |
DR REDDYS LABORATORIES | ₹93,261.6 Cr | -3% | -6.5% | -12.7% | Stock Analytics |
ALKEM LABORATORIES Share Price vs Sensex
Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
ALKEM LABORATORIES | 0.6% |
-8.4% |
-8.5% |
SENSEX | -3.4% |
-4.4% |
0.6% |
You may also like the below Video Courses